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ABSTRACT 
Valproate is a known human and animal teratogen that 
produces neural-tube defects. Valproate is also known to 
produce fetal death and a variety of fetal deformities. The 
present study considered the role of val pro ate as a behavioral 
teratogen in rats. Pregnant rats were administered saline or 
valproate, or simply handled at 10 days gestation and the 
offspring tested for a variety of behaviors and physical mea-
sures. Valproate-exposed animals demonstrated lags in the 
emergence of swimming behavior, negative geotaxis and 
weight gain. This evidence points to val pro ate being a behav-
ioral teratogen producing delays in neuromuscular develop-
ment. 
t t t 
Neural-tube defects (NTDS), such as spina-bifid a (SB), 
are one of the most prevalent forms of congenital de-
fects, accounting for perhaps 15 percent of perinatal 
deaths. Estimates indicate 0.4 to 1.0 of every 1000 
American births have some form of SB. In the United 
States some 1500 babies are born with myelomeningo-
cele, a clinically important form of SB, each year. 
The consequences of SB are not limited to the exter-
nal physical deformities and disability. Members of the 
SB population are often labeled as distractible, restless 
and inattentive and are beginning to be diagnosed and 
treated for attention deficit disorder (Anderson and 
Spain 1977, Horn et al. 1985). The early sensorimotor 
precursors of intelligence (object permanence, develop-
ment of schemas, object relations in space) in infants 
with SB are delayed or reduced, compared to their 
nonhandicapped peers, indicating a developmental lag 
(Morrow and Wachs 1992). Humans with SB usually 
have accompanying hydrocephalus and/or Arnold-Chiari 
Malformation (ACM) where the contents of the posterior 
fossa (medulla, pons, cerebellum) are displaced toward 
the foramen magnum. 
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The anticonvulsant valproic acid (VA) and its salts 
(valproic acid sodium/sodium valproate; brand names 
Depakene, Depakote) have been well established as 
human teratogens, with an incidence of SB at 5 times 
greater than usual for mothers taking this drug (for 
review see Vorhees 1986). Valproic acid is a widely 
used anticonvulsant and represents a substantial risk 
to the epileptic mother needing such medication. 
Valproic acid is of additional interest because of the 
development of an animal model of vA-induced SB (Ehlers 
et al. 1992a, b), making it a useful tool to investigate 
the physiologic processes involved in the formation of 
NTDS. Valproic acid also appears to be a behavioral 
teratogen in humans. Valproic acid has been linked to 
developmental delays, impaired cognitive and social 
functioning, mental retardation, and speech delay in 
humans (Ardinger et al. 1988, Christianson et al. 1994). 
The animal model of VA-induced SB is of further 
interest because rat pups treated with VA develop SB 
and demonstrate a malformation similar to ACM in hu-
mans (Briner and Lieske 1995). Valproate-exposed 
animals also exhibit behavioral changes such as poorer 
maze performance, altered open-field, and hole board 
activity (Vorhees 1987a). 
It is clear that VA is an important human and 
animal teratogen in both the physical and behavioral 
spheres. We have undertaken this study to assess the 
effects of prenatal VA exposure on the emerging neuro-
muscular development of young rats. 
MATERIALS AND METHODS 
Animals 
Nulliparous female Long-Evans rats originally de-
rived from Charles River stock were used. The rats 
were maintained on an ad-lib diet of Purina lab chow 
78 W. Briner 
3.0 
Q,) .... 
0 
(J 
(/) 
C) 
c 2.0 
E 0 Control 
E II Saline 
~ D VA900 (/) 
Q,) 
C) 
nI .... 1.0 Q,) 
> 
< 
0.0 +-------r-'-....... --T'-...... 
4 6 8 10 12 14 18 
Age (days) 
Figure 1. Development of swimming behavior across groups and over time. The VA group significantly lags the control group 
from 6 to 14 days of age. Asterisks (*) indicate a statistically significant lag for the VA group. 
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Figure 2. Negative geotaxis development for each group across ages. The VA exposed group significantly lags behind the control 
and saline treated groups as indicated by an asterisk (*). 
and water and a 12-12 hour light-dark cycle. The 
females were placed with males for 24 hours and the 
presence of a copulatory plug noted, indicating day 0 of 
gestation. Mter we detected a copulatory plug, the 
females were removed from mating and housed sepa-
rately. Just before birth of the pups, the females were 
placed in cages with wood-chip bedding and remained 
there with the pups for the duration ofthe experiment. 
At four days of age the pups were individually identi-
fied by toe clipping. All animals were maintained in 
accordance with federal guidelines and AALAC prin-
ciples, as well as standards established by the Animal 
Welfare Act. This study was approved by the Institu-
tional Animal Care and Use Committee of the Univer-
sity of Nebraska at Kearney. 
Drugs and exposure 
At 10 days gestation the females were injected with 
either physiological saline or VA sodium (Sigma Chemi-
cal, St. Louis) 900mg/kg, subcutaneously as an aqueous 
solution over the hindquarters. This dosage was se-
lected because it is teratogenic yet has minimal impact 
on litter size (Briner and Lieske 1995). Control females 
were simply handled and not injected. Pregnancy was 
otherwise allowed to proceed normally and the date of 
birth of the pups was noted. 
Weight 
Animals were weighed every day of testing on an 
electronic scale to the nearest 0.1 g. 
Swimming 
Pups were tested beginning at 4 days and tested 
every other day until 12 days of age and also at 14 and 
18 days. All tests were performed in the same order for 
each litter. The experimenter was blind to the treat-
ment condition ofthe pups. From a height of six inches 
the pups were dropped into warm water and observed 
for several seconds. Animals were scored in a standard 
fashion (Schapiro et al. 1970, Vorhees et al. 1979) using 
the following criteria: unable to keep nose out of water 
= 0; keep nose out of water but not to top of ears = 1; 
keep nose and top of ears out of water = 2; keep nose, 
top of head and ears at least half-way out of water = 3. 
Righting 
The pups were placed on their backs on a flat hard 
table surface and allowed 30 seconds to right them-
selves. This was scored as pass/fail. The animals were 
not tested for righting at 14 and 18 days of age because 
they universally perform this task. 
Negative geotaxis 
The pups were placed head down on a 15° incline 
and allowed 60 sec to orient head up and remain head 
up for at least 10 sec. This was scored as pass/fail. The 
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animals were not tested for negative geotaxis at 14 and 
18 days of age because they universally perform this 
task. 
Analysis 
Righting and negative geotaxis were analyzed with 
Chi-square. Weight and swimming were analyzed with 
ANOVA with the Scheffe correction for follow-up analy-
ses. 
RESULTS 
General observations 
The numbers oflitters and animals examined were 
as follows: eight litters of control animals for a total of 
91 pups (mean litter size 11.4); seven litters of saline 
treated animals for a total of 76 pups (mean litter size 
10.9); and 12 litters of vA-treated animals for a total of 
97 pups (mean litter size 8.1); these differences were 
not statistically significant (F(2, 24) = 2.14, p = NS). 
None of the three groups of rat pups had any obvious 
deformities, and all seemed generally healthy and oth-
erwise normal, except as indicated below. All groups 
had normal eye and ear opening as well as normal 
emergence of walking. 
Weight 
Weight of the pups was generally consistent until 
14 and 18 days of age when the VA group demonstrated 
a slight lag behind that of both the control and saline 
group (Day 14 weights: 24.5, 25.4 and 22.4 g; Day 18 
weights: 30.4, 31.8, 28.9 g for control, saline, and VA 
groups respectively). The differences on days 14 and 18 
were statistically significant (F(2, 225) = 7.42, P < .001 
and F(2, 220) = 4.72, P < .001, respectively). 
Swimming 
For the sake of clarity, the swimming scores were 
averaged for each group for each day oftesting. The VA 
group consistently lagged behind the other two groups 
in terms of swimming development. At 4 days of age 
there was no significant difference (F(2, 240) = 1.21, P = 
NS) between the groups (all the groups exhibiting little 
development of swimming behavior) and at 18 days of 
age there was no significant difference(F(2, 196) = 2.00,p 
= NS) (all groups had developed to nearly the same 
extent). However, for each ofthe days between, the VA-
treated group lagged (6 days of age F(2, 237) = 27.40,p < 
.05); 8 days of age F(2, 225) = 8.05,p < .05; 10 days of age 
F(2, 204) = 9.83,p < .05; 12 days of age F(2, 218) = 1l.14,p 
< .05; 14 days of age F(2, 209) = 17.83, P < .05). Specifi-
cally, they were the last to advance to a score of 1 (the 
ability to keep the nose out of the water), and the last to 
develop a score of 3 (ability to keep nose and head out of 
water past the middle of the ear). The results are 
graphically displayed in Fig. 1. 
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Righting 
There was no difference in the development of sur-
face righting for the three groups at any age. 
Negative geotaxis. 
While the VA group performed as well as the other 
two groups at 4 days of age (r(2) = .56, P = NS) they 
lagged behind the other groups at 6 (r(2) = 33.23, p < 
. 001), 8 (r(2) = 27.82, P < .001), 10 (r(2) = 18.47, P < 
.001), and (r(2) = 16.75, P < .001) 12 days of age (Fig. 2). 
DISCUSSION 
The developmental toxicity of VA has been docu-
mented in previous studies (Binkerd et al. 1988, Vorhees 
1987b) and the behavioral impacts have been described 
in humans and rats (Ardinger et al. 1988, Christianson 
et al. 1994, Vorhees 1987a). This study again demon-
strates that VA is a teratogen that affects emerging 
behaviors in developing rat pups. The findings of this 
study point to an overall lag in neuromuscular coordi-
nation as a consequence of VA exposure. Swimming 
behavior is considered to be a good index of neuromus-
cular development and integration because ofthe num-
ber of neurological and muscular systems that need to 
be coordinated to bring about effective swimming 
(Kallman 1994). Similarly, negative geotaxis is a mea-
sure of neuromuscular integration that depends on 
information from the inner ear being coordinated with 
muscular activity to orient the animal head up (Kallman 
1994). 
The observation of normal development of surface 
righting, walking, ear and eye opening for the VA group, 
while other behaviors were negatively affected, argues 
that the deficits induced by VA are not global, but rather 
relatively specific. Previous work in our laboratory 
demonstrated that VA induces a form of the Arnold-
Chiari malformation (Briner and Lieske 1995) that 
affects the brainstem and cerebellar region. This would 
be consistent with the findings presented here. The 
cerebellum and brainstem are required to coordinate 
complex sensory input required for tasks such as swim-
ming and vestibular responses, and their alteration 
would presumably be reflected in development. Other 
behaviors, such as surface righting and walking, may 
be more dependent on motor programs (Grillner and 
Wallen 1985) and therefore less susceptible to moder-
ate anatomic disruptions. 
The differences in weight seen at 14 and 18 days of 
age are most probably due to valproate's effect on a 
system not examined in this study. In any event, the 
differences are small and do not appear to directly 
impact the animals' performance on tests. 
Overall, the results ofthis study point to VA being a 
behavioral teratogen, at least as expressed in the be-
havior of pre weanling rats. Valproate produces deficits 
in neuromuscular development and coordination that 
fade as the animal develops. This corresponds well to 
data from humans where the spina bifida population 
often experiences developmental lags but typically "catch 
up" to mainstream groups, although other permanent 
deficits are often seen . 
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